Global Synthetic Hormones Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Synthetic Hormones Market Insights, Forecast to 2034
Synthetic hormones are foreign molecules that are produced in a laboratory and used to cure hormonal imbalances in men and women. Synthetic hormones such as progesterone, estrogen, thyroid hormone, testosterone, and insulin are commonly utilized to treat a variety of medical problems. These hormones are extremely active even at low doses, and long-term usage of synthetic hormones has been related to a variety of adverse effects. Some synthetic hormones on the market include Ferring B.V.'s Zomacton injectable (Somatropin), which is used to treat growth hormone insufficiency in children.
Global Synthetic Hormones market is expected to reach to US$ 219 million in 2024, with a positive growth of %, compared with US$ 214 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Synthetic Hormones industry is evaluated to reach US$ 270.8 million in 2029. The CAGR will be 3.6% during 2024 to 2029.
The synthetic hormones market refers to the segment of the pharmaceutical industry that focuses on the development, production, and sale of synthetic or artificially produced hormones. Synthetic hormones are designed to mimic the effects of naturally occurring hormones in the body. Synthetic hormones play a crucial role in various medical treatments and therapies. They are used for a range of purposes, including hormone replacement therapy (HRT), contraception, fertility treatments, and management of hormonal disorders. Common synthetic hormones include estrogen, progesterone, testosterone, and various forms of birth control hormones. The market for synthetic hormones has witnessed significant growth in recent years due to several factors. One of the key drivers is the increasing prevalence of hormonal imbalances and disorders, such as menopause, polycystic ovary syndrome (PCOS), and hypogonadism. Additionally, the growing aging population and the increasing interest in anti-aging treatments have also contributed to the market expansion. Advancements in the field of biotechnology and pharmaceutical research have led to the development of advanced synthetic hormone formulations, including sustained-release formulations and combination therapies. These innovations offer improved efficacy, convenience, and patient compliance, further driving the market growth. The market is characterized by the presence of both generic and branded synthetic hormone products. Generic drugs are usually more affordable, leading to their widespread adoption, especially in developing regions. However, branded products continue to dominate the market in developed countries due to their brand recognition, marketing strategies, and perceived quality.
Report Covers
This report presents an overview of global Synthetic Hormones market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Synthetic Hormones market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
Pfizer, Inc.
McGuff Pharmaceuticals, Inc.
Lyndra Therapeutics, Inc.
Ferring B. V.
Slayback Pharma
Lupin Pharmaceuticals, Inc.
Acerus Pharmaceuticals Corporation
IBSA Institut Biochimique SA
Endo International plc
American Reagent, Inc.
Merck Serono
Novo Nordisk
F. Hoffmann-La Roche
BioPartners
Eli Lilly
Segment by Type
Steroid Hormones
Peptide Hormone
Amino Acid Derivatives
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Synthetic Hormones plant distribution, commercial date of Synthetic Hormones, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Synthetic Hormones introduction, etc. Synthetic Hormones Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Synthetic Hormones
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Global Synthetic Hormones market is expected to reach to US$ 219 million in 2024, with a positive growth of %, compared with US$ 214 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Synthetic Hormones industry is evaluated to reach US$ 270.8 million in 2029. The CAGR will be 3.6% during 2024 to 2029.
The synthetic hormones market refers to the segment of the pharmaceutical industry that focuses on the development, production, and sale of synthetic or artificially produced hormones. Synthetic hormones are designed to mimic the effects of naturally occurring hormones in the body. Synthetic hormones play a crucial role in various medical treatments and therapies. They are used for a range of purposes, including hormone replacement therapy (HRT), contraception, fertility treatments, and management of hormonal disorders. Common synthetic hormones include estrogen, progesterone, testosterone, and various forms of birth control hormones. The market for synthetic hormones has witnessed significant growth in recent years due to several factors. One of the key drivers is the increasing prevalence of hormonal imbalances and disorders, such as menopause, polycystic ovary syndrome (PCOS), and hypogonadism. Additionally, the growing aging population and the increasing interest in anti-aging treatments have also contributed to the market expansion. Advancements in the field of biotechnology and pharmaceutical research have led to the development of advanced synthetic hormone formulations, including sustained-release formulations and combination therapies. These innovations offer improved efficacy, convenience, and patient compliance, further driving the market growth. The market is characterized by the presence of both generic and branded synthetic hormone products. Generic drugs are usually more affordable, leading to their widespread adoption, especially in developing regions. However, branded products continue to dominate the market in developed countries due to their brand recognition, marketing strategies, and perceived quality.
Report Covers
This report presents an overview of global Synthetic Hormones market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Synthetic Hormones market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Pfizer, Inc.
McGuff Pharmaceuticals, Inc.
Lyndra Therapeutics, Inc.
Ferring B. V.
Slayback Pharma
Lupin Pharmaceuticals, Inc.
Acerus Pharmaceuticals Corporation
IBSA Institut Biochimique SA
Endo International plc
American Reagent, Inc.
Merck Serono
Novo Nordisk
F. Hoffmann-La Roche
BioPartners
Eli Lilly
Segment by Type
Steroid Hormones
Peptide Hormone
Amino Acid Derivatives
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Synthetic Hormones plant distribution, commercial date of Synthetic Hormones, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Synthetic Hormones introduction, etc. Synthetic Hormones Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Synthetic Hormones
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports